Survey among Italian experts on existing vaccines' role in limiting antibiotic resistance.

Federico Marchetti, Rosa Prato, Pierluigi Viale
Author Information
  1. Federico Marchetti: GSK, Verona, Italy. ORCID
  2. Rosa Prato: Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy. ORCID
  3. Pierluigi Viale: IRCCS Policlinico Sant'Orsola, Infectious Disease Unit, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.

Abstract

Antimicrobial resistance (AMR) is a major public health problem threatening to reverse the progress made against infectious diseases. The rapid increase of AMR exposes Italian hospitals at increased risk of untreatable infections. Vaccinations can potentially limit AMR by reducing the number of infected cases in need of antibiotics. We conducted a survey among Italian vaccine experts to record their opinion regarding the role of vaccinations against antibiotic resistance (ABR). Among 80 invited experts, 51 answered all questions. Most respondents were experts in hygiene and preventive medicine (56.9%) and aged >50 years (72.6%). ABR was a priority concern in the daily professional activity of 82.4% of respondents. Overall, 47.1% of respondents believed that all vaccinations included in the vaccination calendar played a role against ABR: 92.2% for pertussis vaccination followed by 88.2%, 74.5%, and 70.6% for meningococcus, measles, and varicella vaccinations, respectively. Almost all respondents agreed that the role of vaccinations against ABR should be clearly expressed in the national vaccination guidelines (96.1%) and Scientific Societies should take an explicit position on the issue (92.2%). These results show that Italian experts have recognized the vaccinations' potential role in limiting ABR and guidelines from the appropriate scientific and governmental authorities are needed.

Keywords

References

  1. Prev Med. 2019 Apr;121:99-104 [PMID: 30763627]
  2. S Afr Med J. 2015 Apr 06;105(5):325 [PMID: 26242647]
  3. Infect Control Hosp Epidemiol. 2018 Mar;39(3):316-322 [PMID: 29402339]
  4. Int J Infect Dis. 2021 Mar;104:250-254 [PMID: 33434666]
  5. Int J Infect Dis. 2020 Jan;90:188-196 [PMID: 31622674]
  6. Hum Vaccin Immunother. 2015;11(1):63-71 [PMID: 25483517]
  7. Microbiol Mol Biol Rev. 2010 Sep;74(3):417-33 [PMID: 20805405]
  8. Nat Rev Microbiol. 2021 May;19(5):287-302 [PMID: 33542518]
  9. Hum Vaccin Immunother. 2016 Oct 2;12(10):2536-2545 [PMID: 27246119]
  10. Perspect Medicin Chem. 2014 Aug 28;6:25-64 [PMID: 25232278]
  11. Front Public Health. 2020 Nov 04;8:535668 [PMID: 33251170]
  12. World J Emerg Surg. 2018 Jun 28;13:27 [PMID: 29988647]
  13. Crit Rev Food Sci Nutr. 2017 Sep 2;57(13):2857-2876 [PMID: 26464037]
  14. Nat Rev Microbiol. 2020 Aug;18(8):409-410 [PMID: 32488173]
  15. Am J Infect Control. 2020 Sep;48(9):1129-1130 [PMID: 32603851]
  16. J Hosp Infect. 2019 Apr;101(4):428-439 [PMID: 30099092]
  17. Proc Natl Acad Sci U S A. 2018 Dec 18;115(51):12896-12901 [PMID: 30559195]
  18. J Mark Access Health Policy. 2015 Aug 12;3: [PMID: 27123182]
  19. mBio. 2016 Jun 07;7(3): [PMID: 27273824]
  20. Antimicrob Resist Infect Control. 2021 Jan 29;10(1):21 [PMID: 33514424]
  21. Euro Surveill. 2020 Nov;25(45): [PMID: 33183403]
  22. Clin Infect Dis. 2021 Aug 16;73(4):e1011-e1017 [PMID: 33493317]
  23. Expert Rev Vaccines. 2019 May;18(5):439-455 [PMID: 30887849]
  24. F1000Res. 2019 Sep 24;8:1685 [PMID: 31737260]
  25. Clin Microbiol Infect. 2016 May;22 Suppl 3:S37-62 [PMID: 27062097]
  26. Clin Microbiol Infect. 2019 Oct;25(10):1213-1225 [PMID: 31284031]
  27. J Prev Med Hyg. 2020 Jul 04;61(2):E152-E161 [PMID: 32802999]
  28. Clin Microbiol Infect. 2021 Jan;27(1):9-11 [PMID: 32979569]
  29. Ann Med. 2020 Sep;52(6):283-299 [PMID: 32597236]
  30. PLoS One. 2021 Jan 29;16(1):e0246156 [PMID: 33513169]
  31. Clin Microbiol Infect. 2021 Feb 16;: [PMID: 33601010]
  32. Hum Vaccin Immunother. 2020;16(2):340-348 [PMID: 31403385]
  33. Euro Surveill. 2019 Oct;24(42): [PMID: 31640840]

MeSH Term

Chickenpox Vaccine
Drug Resistance, Microbial
Italy
Surveys and Questionnaires
Vaccination

Chemicals

Chickenpox Vaccine

Word Cloud

Created with Highcharts 10.0.0expertsroleresistanceItalianvaccinationsABRrespondentsvaccinationAMR2%amongantibiotic6%1%92pertussismeaslesvaricellaguidelineslimitingAntimicrobialmajorpublichealthproblemthreateningreverseprogressmadeinfectiousdiseasesrapidincreaseexposeshospitalsincreasedriskuntreatableinfectionsVaccinationscanpotentiallylimitreducingnumberinfectedcasesneedantibioticsconductedsurveyvaccinerecordopinionregardingAmong80invited51answeredquestionshygienepreventivemedicine569%aged>50 years72priorityconcerndailyprofessionalactivity824%Overall47believedincludedcalendarplayedABR:followed88745%70meningococcusrespectivelyAlmostagreedclearlyexpressednational96ScientificSocietiestakeexplicitpositionissueresultsshowrecognizedvaccinations'potentialappropriatescientificgovernmentalauthoritiesneededSurveyexistingvaccines'AntibioticItalyMenACWYMenBmeningococcalvaccines

Similar Articles

Cited By